|
Re: Renal trial delayed (again)
|
3
|
Resverlogix Corp.
|
Sep 28, 2017 11:01AM
|
|
Re: Renal trial delayed (again)
|
3
|
Resverlogix Corp.
|
Sep 30, 2017 09:53PM
|
|
Re: Report of exempt distribution
|
4
|
Resverlogix Corp.
|
May 08, 2020 06:51AM
|
|
Re: Report of exempt distribution on SEDAR
|
2
|
Resverlogix Corp.
|
Sep 10, 2022 10:27AM
|
|
Re: Report of exempt distribution on SEDAR
|
4
|
Resverlogix Corp.
|
Sep 10, 2022 10:52AM
|
|
Re: Reports of Exempt Distribution
|
2
|
Zenith Epigenetics
|
Feb 09, 2023 07:23AM
|
|
Re: Reports of Exempt Distribution
|
3
|
Zenith Epigenetics
|
Feb 09, 2023 08:30AM
|
|
Re: Reports of exempt distribution on SEDAR
|
6
|
Resverlogix Corp.
|
Mar 29, 2018 10:41AM
|
|
Re: Response & what I will attempt...
|
2
|
Zenith Epigenetics
|
Aug 15, 2020 08:47AM
|
|
Re: Response & what I will attempt...
|
1
|
Zenith Epigenetics
|
Aug 15, 2020 07:09PM
|
|
Re: Response - opp next agm? Brutal imo
|
4
|
Resverlogix Corp.
|
Feb 27, 2024 10:05AM
|
|
Re: RESVERLOGIX AND MEDISON PHARMA LTD. ANNOUNCE STRATEGIC LICENSING AGREEMENT
|
3
|
Resverlogix Corp.
|
Jan 08, 2018 10:39AM
|
|
Re: Resverlogix Announces $13 Million Private Placement
|
1
|
Resverlogix Corp.
|
Oct 06, 2020 08:35AM
|
|
Re: Resverlogix Announces $13 Million Private Placement
|
7
|
Resverlogix Corp.
|
Oct 06, 2020 09:05AM
|
|
Re: Resverlogix Announces Apabetalone Prior to SARS-CoV-2 (COVID-19) Exposure Reduces Viral Infection – Confirms Plans for COVID-19 Clinical Trial
|
7
|
Resverlogix Corp.
|
Dec 22, 2020 08:19AM
|
|
Re: Resverlogix Announces Apabetalone Prior to SARS-CoV-2 (COVID-19) Exposure Reduces Viral Infection – Confirms Plans for COVID-19 Clinical Trial
|
1
|
Resverlogix Corp.
|
Dec 22, 2020 10:04AM
|
|
Re: Resverlogix Announces Apabetalone Prior to SARS-CoV-2 (COVID-19) Exposure Reduces Viral Infection – Confirms Plans for COVID-19 Clinical Trial
|
5
|
Resverlogix Corp.
|
Dec 22, 2020 01:34PM
|
|
Re: Resverlogix Announces Change in Fiscal Year-End to December 31
|
2
|
Resverlogix Corp.
|
Mar 15, 2021 07:42AM
|
|
Re: Resverlogix Announces Conversion of US$12 Million Debenture Strengthening Balance Sheet
|
4
|
Resverlogix Corp.
|
Oct 14, 2020 12:41PM
|
|
Re: Resverlogix Announces Conversion of US$12 Million Debenture Strengthening Balance Sheet
|
4
|
Resverlogix Corp.
|
Oct 14, 2020 04:53PM
|
